An Updated Review of a Novel Drug Delivery System in Medicated Chewing Gum
Chewing gums are mobile drug delivery systems. Unlike chewable tablets medicated gums are not supposed to be swallowed and may be removed from the site of application without resort to invasive means and medicated chewing gum MCG is solid, single dose preparation. As for as patient convenience is concerned it is discrete and easy administration without water promotes higher compliance. Since it can be taken anywhere, a chewing gum formulation is an excellent choice for acute medication. The advantages for children and for patients who find swallowing tablets difficult are obvious. The medicated chewing gums are solid, single dose preparations with a base consisting mainly of gums that are intended to be chewed, but not swallowed. They contain one or more active substances, which are released by chewing and are intended to be used for local treatment of mouth diseases or systemic delivery after absorption through the buccal mucosa. This concept is supported by statements that chewing sugar free gum can help reduce the risk of dental caries (cavities). The objective of this systematic study is to appraise existing evidence concerning a possible therapeutic effect of sugar- free chewing gum for patients. MCG represents the newest system with potential uses in pharmaceuticals, over the counter medicines and neutraceuticals.
2. Edgar W, Geddes D. Chewing gum and dental health - A review. Br Dent J 1990; 168:173-177.
3. Conway B. Chewing gum as a drug delivery system. The Drug Delivery Companies Report Autumn/Winter; 2003:33-35.
4. Patel PV, Desai TR, Dedakiya AS, Bandhiya HM. Medicated chewing gum: A review. IJUPLS 2011; 1(1):111-128.
5. Biswal PK and Kumar A. An Updated Review on Medicated Chewing Gum. IJAPBC 2013; 2(2):351-59.
6. Jacobsen J, Christrup LL, Jensen NH. Medicated chewing gum. Am J Drug Deliv 2004; 2:75-88.
7. Cloys L, Christen A, Christen J. The development & history of chewing gum. Bulletin of the History of Dentistry 1992; 40:57-65.
8. Owens, L. Gumtech to Produce Aspergum and Chooz for Schering- Plough Health Care Products. Business Wire 1998.
9. Khanekar P, Mhatre S, Momin M. Medicated Chewing Gum: A Potential Drug Delivery System. IJPFR 2012; 2(4):64-75.
10. Morjaria Y, Irwin WJ, Barnett PX, Chanvv RS, Conway BR. In vitro Release of nicotine from chewing gum formulations. Dissolution Technologies 2004; 12-15.
11. Naik H, Gupta S. Medicated Chewing Gums- Updated Review. IJPRD 2011; 2 (8):66-76.
12. Jacobsen J, Christrup LL, Jensen NH. Medicated chewing gum: Pros and Cons. Am J Drug Deliv 2004; 2(2):75-88.
13. Goldberg LD, Ditchek NT. Chewing gum diarrhea, Am J Dig Dis 1978; 23(6):568-62.
14. Addy M, Roberts WR. Comparison of the bis iguanid antiseptics alexandrine and chlorhexidine II. Clinical and in vitro staining properties. J Clin. Periodontol 1981; 8(3):220-30.
15. Munksgaard EC, Nolte J, Kristensen K. Adherence of chewing gum to dental restorative materials. Am J Dent 1995; 8(3):137-139.
16. Weil AT. Coca leaf as a therapeutic agent. Am J Drug Alcohol Abuse 1978; 5(1):75-86.
17. Martin R. Chewing gum. BMJ 1985; 290:1232-1236.
18. Edgar WM, Dawes C, O’Mullane D. Saliva and oral health: An essential overview for the health professional. 3rd ed., British Dental Association Publication, London; 2004.
19. Sharma NS, Arjariya PA, Jat RC, Fiza F, Sharma G, Rathore SA, Tiwari R. An overview on medicated chewing gum and its applications. IJPFR 2013; 4(3):3158-73.
20. Zyck DJ, Greenberg MJ, Barkla DG, Marske SW, Schnell PG, Mazzone P.. Method of making coated chewing gum products containing various antacids. US Patent 2003; 6:635-45.
21. Kahtani D. Chewing gum: trick or treat.SDJ 1999; 11(1):27-34.
22. Athanikar NK, Gubler SA. Process for manufacturing a pharmaceutical chewing gum. US Patent 2001; 6:322-828.
23. Subraman CR, Kirshnayya B. Tableted chewing gum composition and method of preparation. US Patent 1988; 4:753- 805
24. Keizo M, Yokomichi FY. Process for the preparation of chewing gum. US Patent 1976; 4:321.
25. European Pharmacopoeia. Strasbourg: European directorate for the quality of medicines. Chewing gums: Medicated. 5th ed. 2004: 260-601.
26. Shah KR, Mehta TA. Medicated chewing gum- A mobile oral drug delivery system. Int. J. Pharm Tech Res. 2014; 6(1):35-48.
27. Lieberman HA, Lachman L, Schwartz JB., Pharmaceutical Dosage Forms: Tablets. II ed., Lippincott Williams & Wilkins, New York; 1990, 1: 367-415.
28. Barabolak R, Hoerman K, Kroll N. Chewing gum profiles. US Population. Community Dent Oral Epidemiol 1999; 19:125-26.
29. Jacobsen J, Bjerregaard S, Pedersen M. Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity- drug super saturation, toxicity on TR146 cells and release from a delivery system. Eur J Pharm Biopharm 1999; 48 (3):217-24.
30. Gudas VV, Reed MA, Schnell PG, Tyrpin HT, Russell MP, Witkewitz DL. Method of controlling release of caffeine in chewing gum. US Patent 1998; 6:165-516.
31. Yang RK. Encapsulation composition for use with chewing gum and edible products. US Patent 1988; 4:740-376.
32. Siewert M, Dress man JB, Brown C, Shah VP. AAPS guidelines for dissolution in vitro release testing of novel special dosage forms. Dissolution Techno 2003; 2:6–15.
33. Yang X, Wang G, Zhang X. Release kinetics of catechism from chewing gum. J Pharm Sci 2004; 93(2):293–99.
34. Shah VP, Derdzinski K, Ewing G. A performance test for topical and transdermal dosage forms. Pharm Forum 2006; 32(5):1586–89.
35. Kvist LC, Andersson SB, Berglund J, Wennergren B, Fors SM. Equipment for drug release testing of medicated chewing gums. J Pharm Biomed Anal. 2000; 22(3):405–11.
36. European Directorate for the Quality of Medicines, Council of Europe, European Pharmacopoeia. Suppl. General Chapter 2.9.25: Chewing Gum, Medicated Release from. 3rd Ed. Strasbourg, France; European Directorate for the Quality of Medicines, Council of Europe; 2000:104.
37. European Directorate for the Quality of Medicines, Council of Europe. European Pharmacopoeia. Suppl. 5.2. General Monograph 2.9.25: Dissolution Test for Medicated Chewing Gums. 5th Ed. Strasbourg, France 2005; 3116–17.
38. Kvist C, Andersson SB, Fors S, Wennergren B, Berglund J. Apparatus for studying in vitro drug release from medicated chewing gums. Int J Pharm 1999; 189(1):57–65.
39. Kvist LC, Andersson SB, Berglund J, Wennergren B, Fors SM. Equipment for drug release testing of medicated chewing gums. J Pharm Biomed Anal 2000; 22(3):405–11.
40. Vries ME, Bodde HE, Verhoef JC, Junginger HE, Crit Rev Ther Drug Carr Sys, 1991.
41. Mochizuki K, Yokomichi F. Process for preparation of chewing gum. US Patent 1976; 000321.
42. Subraman R, John M, Jack E, Edward J, Carlos D, Gitchell Joe. Medicated chewing gum delivery system for nicotine, US Patent 2002; 6344222.
43. Amir’s; Shojaei; Bret.Berner; Xiaoling.Li. Pharma Res 1998; 15(8):1182-88.
44. Hughes, Lyn, Buccal, Dissolution of active substances 2003; US 2003;0087457.
45. Lieberman HA, Lachman L, Schwartz JB, II edition, Pharmaceutical Dosage Forms, Tablets. 2nd ed., 1990;1:367- 415.
46. Imfeld T. Chewing gum-facts and fiction: a review of gum-chewing and oral health. Crit Rev Oral Biol Med 1999; 10(3):405-19.
47. Pedersen M, Rassing MR. Miconazole chewing gum as a drug delivery system. Drug Dev Ind Pharm 1991; 17(3):411- 20.
48. Christrup LL, Rasmussen SN, Rassing MR.: Chewing gum as a drug delivery system. Formica. Sci Ed 1988; 16:44- 47.
49. Woodford DW, Lesko LJ. Relative bioavailability of aspirin gum. J Pharm Sci 1981; 70(12):1341-43.
50. Tyrpin HT, Russell MP, Witkewitz DL, Johnson SS, Ream RL, Corrival CL. Caffeine coated chewing gum product and process of making. US Patent: 2002; 6:444.
51. Seibel K, Schaffler K, Reitmeir P, Golly I.: A randomized, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation. Arzneimittel forschung 2002; 52(7): 529- 36.
52. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2001; (3):146.
53. Finn SB, Jamison HC. The effect of a dicalcium phosphate chewing gum on caries incidence in children: 30-month results. J Am Dent Assoc 1967; 74(5): 987-95.
54. Smith AJ, Moran J, Dangler LV, Leight RS, Addy M. The efficacy of an anti-gingivitis chewing gum. J Clin Periodontol 1996; 23(1): 19-23.
55. Olive by A, Ekstrand J, Lagerlof F. Effect of salivary flow rate on salivary fluoride clearance after use of a fluoride- containing chewing gum. Caries Res 1987; 21(5):393-401.
56. Etemadzadeh H. Plaque-growth inhibiting effect of chewing gum containing urea hydrogen peroxide. J Clin Periodontol 1991; 18(5): 337-40.
57. Pedersen M, Rassing MR. Miconazole and miconazole nitrate chewing gum as drug delivery system– a practical application of solid dispersion technique. Drug Dev Ind Pharm 1990; 16(1):55- 74.
58. Wertalik F, Bonorden R. Salivary levels of antibiotics from use of neomycin- gramicidin chewing troches. J Pharm Sci 1968; 57(3): 530-31.
59. Smith A. Health Note, the Post-Standard (Syracuse, NY) Nov. 24 2003.
60. Chilcott W. Contraceptive Technology Update on Feb 1 2004.
61. Dodds MWJ, Hsieh SC, Johnson DA. The effect on increased mastication by daily gum chewing on salivary gland output and dental plaque acidogenicity. J Dent Res 1991; 70:1474-78.
62. Barabolak R, Hoerman K, Kroll N, Record D. Chewing gum Profiles in U.S. Population.Commun. Dent. Oral Epidemiol 1991; 19: 125.
64. Ezhumalai K, Ilavarasan P, Rajalakshmi A N, Sathiyaraj U., Murali MugundhanR. Medicated chewing gum- A novel drug delivery technique for systemic and targeted drug delivery. IJPT 2011; 3(1):725-744.